Cleveland BioLabs (CBLI) Announces Positive Results From Protectan CBLB612 Study
Tweet Send to a Friend
Cleveland BioLabs, Inc. (Nasdaq: CBLI) announced the results of a study of the efficacy of Protectan CBLB612, in an animal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
